An investigation of the kallikrein—kinin system in normal and ischaemic rat hearts

1988 ◽  
Vol 16 (6) ◽  
pp. 1011-1012
Author(s):  
IAN D. SWANN ◽  
ALAN ASHFORD ◽  
GRAHAM S. BAILEY
Keyword(s):  
Kinin System ◽  
Rat Hearts ◽  
Kallikrein Kinin System

scholarly journals A local kallikrein-kinin system is present in rat hearts.

Hypertension ◽  
1994 ◽  
Vol 23 (6_pt_2) ◽  
pp. 919-923 ◽  
Author(s):  
H Nolly ◽  
L A Carbini ◽  
G Scicli ◽  
O A Carretero ◽  
A G Scicli
Keyword(s):  
Kinin System ◽  
Rat Hearts ◽  
Kallikrein Kinin System

Einfluss mechanischer Dehnung von alveolären Typ II Zellen auf das Kallikrein-Kinin System

Pneumologie ◽  
2016 ◽  
Vol 70 (S 01) ◽  
Author(s):  
J Knauth ◽  
A Schweinberger ◽  
H Kuhn ◽  
H Wirtz
Keyword(s):  
Kinin System ◽  
Kallikrein Kinin System

scholarly journals Kinins and Kinin Receptors in Cardiovascular and Renal Diseases

2021 ◽  
Vol 14 (3) ◽  
pp. 240
Author(s):  
Jean-Pierre Girolami ◽  
Nadine Bouby ◽  
Christine Richer-Giudicelli ◽  
Francois Alhenc-Gelas
Keyword(s):  
Experimental Studies ◽  
Physiological Role ◽  
Renal Diseases ◽  
Kinin System ◽  
Genetic Studies ◽  
Pharmacological Manipulation ◽  
Kininase Ii ◽  
Kinin Receptors ◽  
Kallikrein Kinin System

This review addresses the physiological role of the kallikrein–kinin system in arteries, heart and kidney and the consequences of kallikrein and kinin actions in diseases affecting these organs, especially ischemic and diabetic diseases. Emphasis is put on pharmacological and genetic studies targeting kallikrein; ACE/kininase II; and the two kinin receptors, B1 (B1R) and B2 (B2R), distinguished through the work of Domenico Regoli and his collaborators. Potential therapeutic interest and limitations of the pharmacological manipulation of B1R or B2R activity in cardiovascular and renal diseases are discussed. This discussion addresses either the activation or inhibition of these receptors, based on recent clinical and experimental studies.

scholarly journals Haplotype-based association study between PRCP gene polymorphisms and essential hypertension in Hani minority group from a remote region of China

2020 ◽  
Vol 21 (4) ◽  
pp. 147032032098131
Author(s):  
Yanrui Wu ◽  
Xingming Pan ◽  
Xiaoxiao Jin
Keyword(s):  
Essential Hypertension ◽  
Gene Polymorphisms ◽  
Minority Group ◽  
Normal Subjects ◽  
Nucleotide Polymorphisms ◽  
Remote Region ◽  
Kinin System ◽  
Average Blood Pressure ◽  
Genetic Impact ◽  
Kallikrein Kinin System

Objective: Prolylcarboxypeptidase (PRCP) is both involved in the Kallikrein-Kinin system (KKS) and renin-angiotensin-aldosterone system (RAAS). This study aimed to determine the genetic impact of PRCP gene polymorphisms on essential hypertension (EH) in an isolated population from a remote region of China. Methods: A haplotype-based study was investigated in 346 EH patients and 346 normal subjects and all samples were Hani minority residents in Southwest China. A total of 11 tag single nucleotide polymorphisms (SNPs) in PRCP gene were tested by polymerase chain reaction-restriction fragment length polymorphism method. Results: Single site analysis found that PRCP gene 3′UTR SNP rs3750931 was associated with EH. The minor allele G of rs3750931 was more prevalent in the EH patients compared to control subjects after Bonferroni correction ( p < 0.05). Moreover, the rs3750931 G allele carriers showed higher average blood pressure (BP) level among the subjects. The H2 (GAGCACTAACA) haplotype without rs3750931 G allele showed the protective effect for EH (OR = 0.68, 95 CI 0.54–0.85, p = 0.001). Conclusion: The present study indicated PRCP gene rs3750931 was associated with the risk of EH. This SNP G allele could be considered as one of risk markers for EH in Hani population.

scholarly journals Kinin B2 Receptor Activation Prevents the Evolution of Alzheimer’s Disease Pathological Characteristics in a Transgenic Mouse Model

2020 ◽  
Vol 13 (10) ◽  
pp. 288
Author(s):  
Marielza Andrade Nunes ◽  
Mariana Toricelli ◽  
Natalia Mendes Schöwe ◽  
Helena Nascimento Malerba ◽  
Karis Ester Dong-Creste ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cell Death ◽  
Functional Disability ◽  
Therapeutic Option ◽  
Receptor Activation ◽  
Hippocampal Culture ◽  
Kinin System ◽  
Organotypic Hippocampal Culture ◽  
Kallikrein Kinin System

Background: Alzheimer’s disease is mainly characterized by remarkable neurodegeneration in brain areas related to memory formation. This progressive neurodegeneration causes cognitive impairment, changes in behavior, functional disability, and even death. Our group has demonstrated changes in the kallikrein–kinin system (KKS) in Alzheimer’s disease (AD) experimental models, but there is a lack of evidence about the role of the KKS in Alzheimer’s disease. Aim: In order to answer this question, we evaluated the potential of the kinin B2 receptors (BKB2R) to modify AD characteristics, particularly memory impairment, neurodegeneration, and Aβ peptide deposition. Methods: To assess the effects of B2, we used transgenic Alzheimer’s disease mice treated with B2 receptor (B2R) agonists and antagonists, and performed behavioral and biochemical tests. In addition, we performed organotypic hippocampal culture of wild-type (WT) and transgenic (TG) animals, where the density of cytokines, neurotrophin BDNF, activated astrocyte marker S100B, and cell death were analyzed after treatments. Results: Treatment with the B2R agonist preserved the spatial memory of transgenic mice and decreased amyloid plaque deposition. In organotypic hippocampal culture, treatment with B2R agonist decreased cell death, neuroinflammation, and S100B levels, and increased BDNF release. Conclusions: Our results indicate that the kallikrein–kinin system plays a beneficial role in Alzheimer’s disease through B2R activation. The use of B2R agonists could, therefore, be a possible therapeutic option for patients diagnosed with Alzheimer’s disease.

scholarly journals Selective kallikrein-kinin system activation in inbred rats differentially susceptible to granulomatous enterocolitis

1996 ◽  
Vol 110 (5) ◽  
pp. 1467-1481 ◽  
Author(s):  
RB Sartor ◽  
RA DeLa Cadena ◽  
KD Green ◽  
A Stadnicki ◽  
SW Davis ◽  
...  
Keyword(s):  
Kinin System ◽  
Inbred Rats ◽  
System Activation ◽  
Kallikrein Kinin System
Sign in / Sign up

Export Citation Format

Share Document